Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 1
1978 1
1979 1
1980 1
1981 2
1982 1
1988 2
1989 3
1990 4
1991 4
1992 3
1993 4
1994 4
1995 5
1996 6
1997 8
1998 5
1999 5
2000 6
2001 5
2002 18
2003 8
2004 8
2005 5
2007 2
2008 3
2009 3
2010 8
2011 4
2012 1
2013 4
2014 5
2015 4
2016 5
2017 10
2018 5
2019 7
2020 9
2021 20
2022 10
2023 14
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

213 results

Results by year

Filters applied: . Clear all
Page 1
Dexamethasone in Hospitalized Patients with Covid-19.
RECOVERY Collaborative Group; Horby P, Lim WS, Emberson JR, Mafham M, Bell JL, Linsell L, Staplin N, Brightling C, Ustianowski A, Elmahi E, Prudon B, Green C, Felton T, Chadwick D, Rege K, Fegan C, Chappell LC, Faust SN, Jaki T, Jeffery K, Montgomery A, Rowan K, Juszczak E, Baillie JK, Haynes R, Landray MJ. RECOVERY Collaborative Group, et al. N Engl J Med. 2021 Feb 25;384(8):693-704. doi: 10.1056/NEJMoa2021436. Epub 2020 Jul 17. N Engl J Med. 2021. PMID: 32678530 Free PMC article. Clinical Trial.
Overall, 482 patients (22.9%) in the dexamethasone group and 1110 patients (25.7%) in the usual care group died within 28 days after randomization (age-adjusted rate ratio, 0.83; 95% confidence interval [CI], 0.75 to 0.93; P<0.001). The proportional and absolute between …
Overall, 482 patients (22.9%) in the dexamethasone group and 1110 patients (25.7%) in the usual care group died within 28 days after randomi …
Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine.
Heath PT, Galiza EP, Baxter DN, Boffito M, Browne D, Burns F, Chadwick DR, Clark R, Cosgrove C, Galloway J, Goodman AL, Heer A, Higham A, Iyengar S, Jamal A, Jeanes C, Kalra PA, Kyriakidou C, McAuley DF, Meyrick A, Minassian AM, Minton J, Moore P, Munsoor I, Nicholls H, Osanlou O, Packham J, Pretswell CH, San Francisco Ramos A, Saralaya D, Sheridan RP, Smith R, Soiza RL, Swift PA, Thomson EC, Turner J, Viljoen ME, Albert G, Cho I, Dubovsky F, Glenn G, Rivers J, Robertson A, Smith K, Toback S; 2019nCoV-302 Study Group. Heath PT, et al. N Engl J Med. 2021 Sep 23;385(13):1172-1183. doi: 10.1056/NEJMoa2107659. Epub 2021 Jun 30. N Engl J Med. 2021. PMID: 34192426 Free PMC article. Clinical Trial.
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
RECOVERY Collaborative Group. RECOVERY Collaborative Group. Lancet. 2021 May 1;397(10285):1637-1645. doi: 10.1016/S0140-6736(21)00676-0. Lancet. 2021. PMID: 33933206 Free PMC article. Clinical Trial.
Overall, 621 (31%) of the 2022 patients allocated tocilizumab and 729 (35%) of the 2094 patients allocated to usual care died within 28 days (rate ratio 0.85; 95% CI 0.76-0.94; p=0.0028). Consistent results were seen in all prespecified subgroups of patients, including tho …
Overall, 621 (31%) of the 2022 patients allocated tocilizumab and 729 (35%) of the 2094 patients allocated to usual care died within 28 days …
Neuromuscular blockers in early acute respiratory distress syndrome.
Papazian L, Forel JM, Gacouin A, Penot-Ragon C, Perrin G, Loundou A, Jaber S, Arnal JM, Perez D, Seghboyan JM, Constantin JM, Courant P, Lefrant JY, Guérin C, Prat G, Morange S, Roch A; ACURASYS Study Investigators. Papazian L, et al. N Engl J Med. 2010 Sep 16;363(12):1107-16. doi: 10.1056/NEJMoa1005372. N Engl J Med. 2010. PMID: 20843245 Free article. Clinical Trial.
RESULTS: The hazard ratio for death at 90 days in the cisatracurium group, as compared with the placebo group, was 0.68 (95% confidence interval [CI], 0.48 to 0.98; P=0.04), after adjustment for both the baseline PaO2:FIO2 and plateau pressure and the Simplified Acute Phys …
RESULTS: The hazard ratio for death at 90 days in the cisatracurium group, as compared with the placebo group, was 0.68 (95% confidence inte …
Automated Insulin Delivery in Women with Pregnancy Complicated by Type 1 Diabetes.
Lee TTM, Collett C, Bergford S, Hartnell S, Scott EM, Lindsay RS, Hunt KF, McCance DR, Barnard-Kelly K, Rankin D, Lawton J, Reynolds RM, Flanagan E, Hammond M, Shepstone L, Wilinska ME, Sibayan J, Kollman C, Beck R, Hovorka R, Murphy HR; AiDAPT Collaborative Group. Lee TTM, et al. N Engl J Med. 2023 Oct 26;389(17):1566-1578. doi: 10.1056/NEJMoa2303911. Epub 2023 Oct 5. N Engl J Med. 2023. PMID: 37796241 Clinical Trial.
The mean percentage of time that the maternal glucose level was in the target range was 68.210.5% in the closed-loop group and 55.612.5% in the standard-care group (mean adjusted difference, 10.5 percentage points; 95% confidence interval [CI], 7.0 to 14.0; P<0.001). Re …
The mean percentage of time that the maternal glucose level was in the target range was 68.210.5% in the closed-loop group and 55.612.5% in …
Re: Cross-Sectional Study of Determinants of Upper and Lower Urinary Tract Outcomes in Adults with Spinal Dysraphism--New Recommendations for Urodynamic Followup Guidelines?: P. W. Veenboer, J. L. Bosch, P. F. Rosier, P. Dik, F. W. van Asbeck, T. P. de Jong and L. M. de Kort J Urol 2014;192:477-482.
Oakeshott P, Poulton A, Hunt GM. Oakeshott P, et al. J Urol. 2015 Dec;194(6):1827-8. doi: 10.1016/j.juro.2015.07.093. Epub 2015 Sep 4. J Urol. 2015. PMID: 26354884 No abstract available.
Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial.
Feig DS, Donovan LE, Corcoy R, Murphy KE, Amiel SA, Hunt KF, Asztalos E, Barrett JFR, Sanchez JJ, de Leiva A, Hod M, Jovanovic L, Keely E, McManus R, Hutton EK, Meek CL, Stewart ZA, Wysocki T, O'Brien R, Ruedy K, Kollman C, Tomlinson G, Murphy HR; CONCEPTT Collaborative Group. Feig DS, et al. Lancet. 2017 Nov 25;390(10110):2347-2359. doi: 10.1016/S0140-6736(17)32400-5. Epub 2017 Sep 15. Lancet. 2017. PMID: 28923465 Free PMC article. Clinical Trial.
We found a small difference in HbA(1c) in pregnant women using CGM (mean difference -0.19%; 95% CI -0.34 to -0.03; p=0.0207). Pregnant CGM users spent more time in target (68% vs 61%; p=0.0034) and less time hyperglycaemic (27% vs 32%; p=0.0279) than did preg …
We found a small difference in HbA(1c) in pregnant women using CGM (mean difference -0.19%; 95% CI -0.34 to -0.03; p=0.0207). Pregnan …
Intermittently Scanned Continuous Glucose Monitoring for Type 1 Diabetes.
Leelarathna L, Evans ML, Neupane S, Rayman G, Lumley S, Cranston I, Narendran P, Barnard-Kelly K, Sutton CJ, Elliott RA, Taxiarchi VP, Gkountouras G, Burns M, Mubita W, Kanumilli N, Camm M, Thabit H, Wilmot EG; FLASH-UK Trial Study Group. Leelarathna L, et al. N Engl J Med. 2022 Oct 20;387(16):1477-1487. doi: 10.1056/NEJMoa2205650. Epub 2022 Oct 5. N Engl J Med. 2022. PMID: 36198143 Clinical Trial.
The mean baseline glycated hemoglobin level was 8.70.9% in the intervention group and 8.50.8% in the usual-care group; these levels decreased to 7.90.8% and 8.30.9%, respectively, at 24 weeks (adjusted mean between-group difference, -0.5 percentage points; 95% confidence interval …
The mean baseline glycated hemoglobin level was 8.70.9% in the intervention group and 8.50.8% in the usual-care group; these levels decrease …
Validation of the Italian version of the ROSIER scale for stroke patients at triage.
Terzoni S, Destrebecq A, Modaffari F, Prendin F, Ferrara P. Terzoni S, et al. Australas Emerg Care. 2022 Jun;25(2):167-171. doi: 10.1016/j.auec.2021.08.001. Epub 2021 Nov 19. Australas Emerg Care. 2022. PMID: 34810149
BACKGROUND: The ROSIER scale allows rapid evaluation of patients with suspected stroke; this paper presents the validation of an Italian version of the ROSIER scale. ...EFA pointed out 1 factor; the ROSIER-ita explained 59.79% of total variance. Content valid …
BACKGROUND: The ROSIER scale allows rapid evaluation of patients with suspected stroke; this paper presents the validation of an Ital …
213 results